Skip to main content

Table 1 Overview of the clinical characteristics of the "non-relapsed" and "relapsed" cystic echinococcosis patient groups

From: Promising proteins detected by Western blot from Echinococcus granulosus protoscoleces for predicting early post-surgical outcomes in CE-affected Tunisian children

Patients (na) Sex Median age (IQR) in years Cyst localization and typed   Treatment strategy
F M Lungs Liver Multiplee Otherf Surgery only Surgery plus ABZg
NRCEb 39 17 22 8 (4–11) 17 CE1 (13)
CE2 (2)
CE3a (2)
12 CE1 (8)
CE2 (1)
CE3a (2)
CE4 (1)
8 (CE1) 2 (CE1) 21 18
RCEc 20 5 15 8 (6–11) 7 CE1 (6)
CE3a (1)
6 CE1 7 (CE1) 0   17 3
  1. aTotal number of patients
  2. bNRCE. Non-relapsed cystic echinococcosis patients after 3 years post-surgery
  3. cRCE. Relapsed cystic echinococcosis patients at 1 year post-surgery
  4. dCyst classification according to WHO-IWGE [34]
  5. eMultiple localization means that cysts were located in the liver and the lungs (13 cases), the liver, lungs, and peritoneum (one case), and the liver, peritoneum, and brain (one case)
  6. fOther locations indicate two cases: one case with a cyst detected in the spleen and one patient with a peritoneal cyst
  7. gABZ. Albendazole medication was given post-operatively to patients with complicated cases and multicystic disease as 10 mg/kg per day
\